0QLQ

Ypsomed Holding AG

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Ypsomed Holding AG est une entreprise suisse spécialisée dans la conception et la fabrication de dispositifs médicaux pour l'autoinjection et la gestion de l'insuline chez les patients diabétiques.

£ 2.71

1.43 %

Healthcare & Biotech Healthcare & Biotech News Switzerland

Ypsomed Holding AG

£ 2.71

1.43 %

0QLQ

Dispositifs médicaux Diabète Autoinjecteurs Gestion de l'insuline Technologie médicale

Healthcare & Biotech Healthcare & Biotech News Switzerland

Price history of Ypsomed Holding AG

Performance & Momentum

6 Months 33.54 %

1 Year 21.40 %

3 Years 50.17 %

5 Years 81.20 %

Momentum

Unlock this indicator

Strategic Analysis

Ypsomed Holding AG • 2026

Ypsomed Holding AG positions itself as a key player in the medical devices sector, specifically targeting insulin management for diabetic patients. Its business model is built on technological innovation in auto-injection systems, offering strong added value in a growing market supported by the rising prevalence of diabetes.

Strengths

Recognized expertise in the manufacture of specialized medical devices for diabetes
Advanced auto-injector technology improving treatment adherence
Strong presence in Switzerland, a guarantee of quality and reliability

Weaknesses

Recent stock performance under pressure, reflecting commercial or cyclical challenges
High dependence on the specific diabetes market with limited sector diversification

Momentum

Current momentum is moderate, with negative medium-term dynamics, suggesting heightened caution for investors. This trend may reflect adjustments related to competition or regulatory developments, but the long-term outlook remains positive given the company's technological positioning.

Ask our AI about Ypsomed Holding AG

Analysis performed 1 month ago